NEUROMAMA, LTD.

CIK:0001542918|SEC Filings

Nature Of Operations And Continuance Of Business (Narrative) (Details) (USD $)	Oct. 31, 2013
Nature Of Operations And Continuance Of Business Narrative Details
Working capital deficit	$ 25,002

Statements Of Cash Flows (Unaudited) (USD $)	9 Months Ended		32 Months Ended
Statements Of Cash Flows (Unaudited) (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Operating Activities
Net loss for the period	$ (500,811)	$ (9,025)	$ (535,629)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest expense	8,177		8,177
Changes in operating assets and liabilities:
Prepaid expense	4,640	(6,640)
Accounts payable and accured liabilities	480,483	(2,527)	484,433
Due to related party	(9,489)		(9,489)
Net cash used in operating activities	(17,000)	(18,192)	(52,508)
Financing Activities
Proceeds from issuance of common shares		21,600	25,100
Proceeds from loan payable	18,000		18,000
Proceeds from related party loans		4,405	10,489
Net cash provided by financing activities	18,000	26,005	53,589
Change in cash	1,000	7,813	1,081
Cash, beginning of period	81	3,573	81
Cash, end of period	1,081	11,386	1,081
Supplemental disclosures:
Interest paid
Income taxes paid
Non-cash items:
Accounts payable financed by loan payable	467,527		467,527
Website development costs financed by loan payable	1,180,362		1,180,362
Common stock issued for acquisition of domain name	1,000		1,000
Common stock issued for acquisition of library of entertainment assets	$ 17,070,000		$ 17,070,000

Balance Sheets (Unaudited) (USD $)	Oct. 31, 2013	Jan. 31, 2013
Current Assets
Cash	$ 1,081	$ 81
Prepaid expense		4,640
Total Current Assets	1,081	4,721
Non-current Assets
Intangible assets	18,251,362
Total Assets	18,252,443	4,721
Current Liabilities
Accounts payable and accrued liabilities	25,083	3,950
Due to related party	1,000	10,489
Total Current Liabilities	26,083	14,439
Non-current Liabilities
Loan payable	1,665,889
Total Liabilities	1,691,972	14,439
Stockholders' Equity (Deficit)
Common stock, 4,000,000,000 shares authorized, $0.001 par value; 3,169,966,180 and 3,165,000,000 shares issued and outstanding, respectively	3,169,966	3,165,000
Additional paid-in-capital	13,926,134	(3,139,900)
Deficit accumulated during the development stage	535,629	34,818
Total Stockholders' Equity (Deficit)	16,560,471	(9,718)
Total Liabilities and Stockholders' Equity (Deficit)	$ 18,252,443	$ 4,721